Weight-loss drug Wegovy to begin sales in Korea after 16-month wait
Weight-loss drug Wegovy will go on sale in the Korean market next month, about a year and a half after receiving regulatory approval in the country.
According to Novo Nordisk Korea, Wegovy's pre-filled syringe will be released in mid-October. The obesity drug was approved by the Ministry of Food and Drug Safety in April last year.
Wegovy, a once-weekly injectable prescription drug, mimics the action of a gut hormone called GLP-1, helping to regulate appetite and food intake.
BY SHIN HA-NEE [shin.hanee@joongang.co.kr]
No comments
Post a Comment